Patents Assigned to Parnell Pharmaceuticals
  • Patent number: 5248501
    Abstract: Methods, compositions and systems are provided for delivering a drug to the skin or mucosa. The invention involves the use of eriodictyon fluid extract as an excipient in compositions and systems for administering drugs topically, transdermally or transmucosally. The invention also relates to methods of using eriodictyon fluid extract to reduce skin or mucosal irritation and as a moisturizer.
    Type: Grant
    Filed: March 11, 1991
    Date of Patent: September 28, 1993
    Assignee: Parnell Pharmaceuticals
    Inventor: Francis W. Parnell